Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.

Cell-penetrating peptides (CPPs) have been used to overcome the lipophilic barrier of the cellular membranes and deliver large molecules and even small particles inside the cell for their biological actions. CPPs are being used to deliver inside cell a large variety of cargoes such as proteins, DNA, antibodies, contrast (imaging) agents, toxins, and nanoparticular drug carriers including liposomes. In this paper, we have reviewed the delivery of different molecules and particles mediated by TAT, Antp, VP22, and other CPPs as well as potential applications of these delivery systems in different areas of vaccine development, cancer immunotherapy, gene delivery, and cellular imaging.

[1]  S. Fawell,et al.  Tat-mediated protein delivery can facilitate MHC class I presentation of antigens , 1996, Molecular biotechnology.

[2]  W. Sessa,et al.  Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo , 2003, Nature Medicine.

[3]  P. Hwu,et al.  Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. , 2002, The Journal of clinical investigation.

[4]  F. Szoka,et al.  Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. , 1997, Biochemistry.

[5]  M. Johansson,et al.  Cell surface adherence and endocytosis of protein transduction domains. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  A. Weiss,et al.  A disulfide conjugate between anti‐tetanus antibodies and HIV (37–72)Tat neutralizes tetanus toxin inside chromaffin cells , 1999, FEBS letters.

[7]  N. Bresolin,et al.  Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. , 2001, Molecular Therapy.

[8]  Li Sun,et al.  Transduction of TAT fusion proteins into osteoclasts and osteoblasts. , 2002, Biochemical and biophysical research communications.

[9]  K. Wooley,et al.  Nanostructured materials designed for cell binding and transduction. , 2001, Biomacromolecules.

[10]  J. Whitton,et al.  Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity , 2002, Gene Therapy.

[11]  Steven F. Dowdy,et al.  Cell Penetrating Peptides in Drug Delivery , 2004, Pharmaceutical Research.

[12]  M. Giacca,et al.  Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans* , 2001, The Journal of Biological Chemistry.

[13]  M. S. Dilber,et al.  Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting , 2001, Gene Therapy.

[14]  R. Müller,et al.  Oligomers of the Arginine-rich Motif of the HIV-1 TAT Protein Are Capable of Transferring Plasmid DNA into Cells* 210 , 2003, The Journal of Biological Chemistry.

[15]  E. Hildt,et al.  Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens , 2000, Gene Therapy.

[16]  J. Kopeček,et al.  Subcellular trafficking of HPMA copolymer-Tat conjugates in human ovarian carcinoma cells. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[17]  V. Torchilin,et al.  Tat peptide-mediated intracellular delivery of liposomes. , 2003, Methods in enzymology.

[18]  T. Bártfai,et al.  Cargo delivery kinetics of cell-penetrating peptides. , 2001, Biochimica et biophysica acta.

[19]  H. Kleinman,et al.  Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. , 1993, The Journal of biological chemistry.

[20]  F. Sharp,et al.  In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis , 2002, The Journal of Neuroscience.

[21]  G. Nolan,et al.  Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. , 1997, Journal of immunology.

[22]  A. Prochiantz,et al.  Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro , 1995, The Journal of cell biology.

[23]  H. Leonhardt,et al.  A novel approach to induce cell cycle reentry in terminally differentiated muscle cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  B. Eymin,et al.  Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein , 2003, Gene Therapy.

[25]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[26]  M. Johansson,et al.  Positively charged DNA-binding proteins cause apparent cell membrane translocation. , 2002, Biochemical and biophysical research communications.

[27]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[28]  Maurice Green,et al.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein , 1988, Cell.

[29]  Y. Tseng,et al.  Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. , 2002, Molecular pharmacology.

[30]  Ralph Weissleder,et al.  Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. , 2002, Bioconjugate chemistry.

[31]  Vladimir P Torchilin,et al.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Ichinose,et al.  Binding of Cationic α-Helical Peptides to Plasmid DNA and Their Gene Transfer Abilities into Cells* , 1997, The Journal of Biological Chemistry.

[33]  J Barsoum,et al.  Tat-mediated delivery of heterologous proteins into cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Futaki,et al.  Arginine-rich Peptides , 2001, The Journal of Biological Chemistry.

[35]  J. Coll,et al.  VP22-mediated and light-activated delivery of an anti-c-raf1 antisense oligonucleotide improves its activity after intratumoral injection in nude mice. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  Priscille Brodin,et al.  A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.

[37]  D. Lauffenburger,et al.  Receptor‐mediated targeting of gene delivery vectors: Insights from molecular mechanisms for improved vehicle design , 2000, Biotechnology and bioengineering.

[38]  E. Vivés,et al.  TAT peptide internalization: seeking the mechanism of entry. , 2003, Current protein & peptide science.

[39]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[40]  A. Phelan,et al.  Intercellular delivery of functional p53 by the herpesvirus protein VP22 , 1998, Nature Biotechnology.

[41]  Yanli Liu,et al.  Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. , 2004, Bioconjugate chemistry.

[42]  Ralph Weissleder,et al.  Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. , 2002, Bioconjugate chemistry.

[43]  S. Ruben,et al.  Structural and functional characterization of human immunodeficiency virus tat protein , 1989, Journal of virology.

[44]  M. Udey,et al.  Dendritic Cells Transduced with Protein Antigens Induce Cytotoxic Lymphocytes and Elicit Antitumor Immunity1 , 2002, The Journal of Immunology.

[45]  A. Prochiantz,et al.  Trojan peptides: the penetratin system for intracellular delivery. , 1998, Trends in cell biology.

[46]  Eric Vives,et al.  Cell-penetrating Peptides , 2003, The Journal of Biological Chemistry.

[47]  J. E. Lee,et al.  TAT-mediated delivery of human glutamate dehydrogenase into PC12 cells , 2002, Neurochemistry International.

[48]  H. Dosaka-akita,et al.  Fusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool , 2004, British Journal of Cancer.

[49]  Mian Wu,et al.  HIV‐1 TAT‐mediated protein transduction and subcellular localization using novel expression vectors1 , 2002 .

[50]  S. Schwarze,et al.  In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. , 2000, Trends in pharmacological sciences.

[51]  L. Chaloin,et al.  Translocating peptides and proteins and their use for gene delivery. , 2000, Current opinion in biotechnology.

[52]  D. Piwnica-Worms,et al.  Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.

[53]  Soo‐Young Choi,et al.  Transduction of Cu,Zn‐superoxide dismutase mediated by an HIV‐1 Tat protein basic domain into mammalian cells , 2000, FEBS letters.

[54]  D. Piwnica-Worms,et al.  Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate. , 2002, Biochemistry.

[55]  W. Shen,et al.  Quantitative comparison of membrane transduction and endocytosis of oligopeptides. , 2003, Biochemical and biophysical research communications.

[56]  D. Hudson,et al.  Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Schuster,et al.  Transfer of monoclonal antibodies into mammalian cells by electroporation. , 1989, The Journal of biological chemistry.

[58]  H. Inokuchi,et al.  Protein Transduction Domain of HIV-1 Tat Protein Promotes Efficient Delivery of DNA into Mammalian Cells* , 2001, The Journal of Biological Chemistry.

[59]  O. Cochet,et al.  Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression. , 1998, Cancer research.

[60]  S. V. Orlov,et al.  Complexes of Plasmid DNA with Basic Domain 47-57 of the HIV-1 Tat Protein Are Transferred to Mammalian Cells by Endocytosis-mediated Pathways* , 2003, Journal of Biological Chemistry.

[61]  D. Bredt,et al.  Tat protein from human immunodeficiency virus forms a metal-linked dimer. , 1988, Science.

[62]  A. Prochiantz,et al.  Antennapedia homeobox peptide regulates neural morphogenesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Crow,et al.  TAT Protein Transduction Into Isolated Perfused Hearts: TAT–Apoptosis Repressor With Caspase Recruitment Domain Is Cardioprotective , 2002, Circulation.

[64]  M. Yacoub,et al.  Enhanced effect of myocardial gene transfection by VP22-mediated intercellular protein transport. , 2004, Journal of molecular and cellular cardiology.

[65]  M. Giacca,et al.  Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat , 2003, Cancer Gene Therapy.

[66]  Mangay Williams,et al.  Superparamagnetic iron oxide particles transactivator protein-fluorescein isothiocyanate particle labeling for in vivo magnetic resonance imaging detection of cell migration: uptake and durability , 2003, Transplantation.

[67]  B. Wiesner,et al.  Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.

[68]  D. Piwnica-Worms,et al.  Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. , 2002, Bioconjugate chemistry.

[69]  S. Dowdy,et al.  TAT-mediated protein transduction into mammalian cells. , 2001, Methods.

[70]  A. Frankel,et al.  Endocytosis and targeting of exogenous HIV‐1 Tat protein. , 1991, The EMBO journal.

[71]  K. Hruska,et al.  Protein transduction: unrestricted delivery into all cells? , 2000, Trends in cell biology.

[72]  C. Pabo,et al.  Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[73]  D M Crothers,et al.  Fragments of the HIV-1 Tat protein specifically bind TAR RNA. , 1990, Science.

[74]  R. L. Juliano,et al.  Conjugates of Antisense Oligonucleotides with the Tat and Antennapedia Cell-Penetrating Peptides: Effects on Cellular Uptake, Binding to Target Sequences, and Biologic Actions , 2004, Pharmaceutical Research.

[75]  V. Torchilin,et al.  TAT-liposomes: a novel intracellular drug carrier. , 2003, Current protein & peptide science.

[76]  D. Anderson,et al.  Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide. , 1993, Biochemical and biophysical research communications.

[77]  J. Wesche,et al.  Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment. , 2001, Biochemistry.

[78]  A. Prochiantz,et al.  Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.

[79]  T. Lawrence,et al.  Inhibition of NF-κB Activity by a Membrane-Transducing Mutant of IκBα1 , 2002, The Journal of Immunology.

[80]  E. Ruoslahti,et al.  A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin , 1993, The Journal of cell biology.

[81]  R Weissleder,et al.  Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. , 2000, Bioconjugate chemistry.

[82]  P. Stern,et al.  Herpes simplex virus VP22–human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death , 2004, Biotechnology and applied biochemistry.

[83]  R Weissleder,et al.  Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.

[84]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[85]  G. Elliott,et al.  Herpes Simplex Virus Type 1 Tegument Protein VP22 Induces the Stabilization and Hyperacetylation of Microtubules , 1998, Journal of Virology.

[86]  M. Maki,et al.  Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization , 1990, Journal of virology.

[87]  Jindrich Kopecek,et al.  Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. , 2003, Bioconjugate chemistry.

[88]  S. Magdassi,et al.  Liposome transduction into cells enhanced by haptotactic peptides (Haptides) homologous to fibrinogen C-termini. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[89]  V. Torchilin,et al.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[90]  C. Debouck,et al.  Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat , 1990, The Journal of cell biology.

[91]  E. Snyder,et al.  Protein/peptide transduction domains: potential to deliver large DNA molecules into cells. , 2001, Current opinion in molecular therapeutics.

[92]  J. Mai,et al.  Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[93]  J. Bahn,et al.  Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. , 2001, Free radical biology & medicine.

[94]  J. Rothbard,et al.  Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. , 2004, Journal of the American Chemical Society.

[95]  O. Haller,et al.  Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon‐induced Mx proteins. , 1988, The EMBO journal.

[96]  J. Tremblay,et al.  Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. , 2004, Biochemical and biophysical research communications.

[97]  L. Smith,et al.  A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy. , 1998, Biophysical journal.

[98]  E. Choi,et al.  Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells. , 2002, The Journal of general virology.

[99]  Simon C Watkins,et al.  Efficiency of Protein Transduction Is Cell Type-dependent and Is Enhanced by Dextran Sulfate* , 2002, The Journal of Biological Chemistry.

[100]  M. Pooga,et al.  Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[101]  Natalie A. Lissy,et al.  Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration , 1998, Nature Medicine.

[102]  E. Vivés,et al.  Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization. , 1991, Biochemistry.

[103]  M. Belting,et al.  Nuclear Targeting of Macromolecular Polyanions by an HIV-Tat Derived Peptide , 2002, The Journal of Biological Chemistry.

[104]  C. Ricordi,et al.  Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. , 2001, Diabetes.

[105]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[106]  G. Elliott,et al.  Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein , 1997, Cell.

[107]  S. Ohta,et al.  Protection against ischemic brain injury by protein therapeutics , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[108]  R. Schwendener,et al.  Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes , 2004, Cellular and Molecular Life Sciences CMLS.

[109]  E. Kobatake,et al.  Intracellular delivery of antibodies using TAT fusion protein A. , 2003, Biochemical and biophysical research communications.

[110]  P. Robbins,et al.  Evaluation of peptide-mediated transduction in human CD34+ cells. , 2004, Human gene therapy.

[111]  T. Torgerson,et al.  Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.

[112]  K. Ellem,et al.  VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death , 2001, The journal of gene medicine.

[113]  R. Brasseur,et al.  New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[114]  S. Dowdy,et al.  Transduction of full-length Tat fusion proteins directly into mammalian cells: analysis of T cell receptor activation-induced cell death. , 2000, Methods in enzymology.

[115]  H. Wong,et al.  Intracellular delivery of HSP70 using HIV-1 Tat protein transduction domain. , 2003, Biochemical and biophysical research communications.

[116]  A. Prochiantz,et al.  The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.

[117]  T. Hökfelt,et al.  Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo , 1998, Nature Biotechnology.

[118]  Kurt Ballmer-Hofer,et al.  Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.

[119]  D. Papahadjopoulos,et al.  pH‐sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules , 1985, FEBS letters.